Bienvenue dans votre Espace

Découvrez les dernières actualités et naviguez avec le sous-menu.

Capture d’écran 2016-03-14 à 15.32.21

  • LILLE, 6TH SEPTEMBER 2016

    OCR the company revolutionising the selection of effective drug candidates for cancer, raises €1.25m from Newfund, NFA and the management team in order to accelerate its growth.

  • LILLE, 16TH JULY 2015

    OCR and Pierre Fabre’s Phase I Clinical Pharmacology Study published in prestigious Clinical Cancer Research journal.

  • LILLE, O2ND APRIL 2015

    OCR and Ecrins Therapeutics initiate €1.9m “Dog to Man” pioneering translational research programme to advance human and vet oncology treatment.

  • LILLE, 23RD MARCH 2015

    OCR and PRISM announce ground-breaking research collaboration to advance real-time diagnosis using mass spectrometry.

  • LILLE, 30TH JANUARY 2015

    OCR strengthens veterinary and R&D expertise to respond to the needs of the pharmaceutical industry.